Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 21, 2016 16:05 ET | Source: Celladon Corporation

Celladon Announces Results of Special Meeting

SAN DIEGO, March 21, 2016 (GLOBE NEWSWIRE) -- Celladon Corporation (Nasdaq:CLDN) announced today that, based upon the final vote count certified by the independent inspector of elections for the...
March 09, 2016 16:05 ET | Source: Celladon Corporation

ISS and Glass Lewis Recommend Celladon Corporation Shareholders Vote "FOR" Proposed Merger

SAN DIEGO, March 09, 2016 (GLOBE NEWSWIRE) -- Celladon Corporation (Nasdaq:CLDN) announced today that Institutional Shareholder Services ("ISS") and Glass Lewis & Co., two of the leading...
February 10, 2016 16:57 ET | Source: Celladon Corporation

Celladon Sets Date for Special Meeting of Stockholders

SAN DIEGO, Feb. 10, 2016 (GLOBE NEWSWIRE) -- Celladon Corporation (Nasdaq:CLDN) announced today it has set a date for a special meeting of its stockholders to vote on matters related to the proposed...
November 18, 2015 22:36 ET | Source: Celladon Corporation

Eiger BioPharmaceuticals and Celladon Corporation Sign Merger Agreement

--Celladon-Eiger Proposed Merger Creates a Biopharmaceutical Company With Diverse Portfolio of Four Novel Drug Development Programs Addressing Orphan Diseases-- --Concurrent Financing of $39.5...
August 11, 2015 16:15 ET | Source: Celladon Corporation

Celladon Reports Second Quarter 2015 Financial Results

SAN DIEGO, Aug. 11, 2015 (GLOBE NEWSWIRE) -- Celladon Corporation (Nasdaq:CLDN), today announced financial results for the quarter ended June 30, 2015 and recent corporate updates. Second Quarter...
June 26, 2015 06:00 ET | Source: Celladon Corporation

Celladon Corporation Provides Business Update

Process of Seeking Merger or Sale Underway Company Not Pursuing Further Development of Existing Programs SAN DIEGO, June 26, 2015 (GLOBE NEWSWIRE) -- Celladon Corporation (Nasdaq:CLDN),...
June 01, 2015 07:00 ET | Source: Celladon Corporation

Celladon Corporation Announces Strategic Direction Following Review of CUPID2 Data

-- Company to Seek Acquisition or Partnership -- -- Wedbush PacGrow Healthcare Securities Retained as Exclusive Financial Advisor -- -- Paul Cleveland Named Chief Executive Officer -- SAN...
May 14, 2015 16:30 ET | Source: Celladon Corporation

Celladon Reports First Quarter 2015 Financial Results

SAN DIEGO, May 14, 2015 (GLOBE NEWSWIRE) -- Celladon Corporation (Nasdaq:CLDN), a clinical-stage biotechnology company with industry-leading expertise in the development of cardiovascular gene...
April 26, 2015 16:40 ET | Source: Celladon Corporation

Celladon Reports Negative Results for CUPID2 Trial of MYDICAR(R) in Advanced Heart Failure

- Investigational gene therapy fails to meet primary and secondary endpoints - - Investor conference call and webcast Monday at 8:30 a.m. ET (5:30 a.m. PT) - SAN DIEGO, April 26, 2015 (GLOBE...
March 30, 2015 16:05 ET | Source: Celladon Corporation

Celladon Reports Fourth Quarter and Year-End 2014 Financial Results and Recent Highlights

CUPID2 Topline Data Release on Track for Late April Conference Call March 31, 2015 at 8:30 a.m. Eastern Time SAN DIEGO, March 30, 2015 (GLOBE NEWSWIRE) -- Celladon Corporation (Nasdaq:CLDN), a...